Newamsterdam Pharma Company Nv (NAMS)

Apr 21, 2025

Head to Head Survey: NewAmsterdam Pharma (NASDAQ:NAMS) vs. Cyclerion Therapeutics (NASDAQ:CYCN) - Defense World

Apr 21, 2025

Apr 18, 2025

Is NewAmsterdam Pharma Company NV (NASDAQ: NAMS) A Good Investment Now? - Stocksregister

Apr 18, 2025

Apr 18, 2025

Newamsterdam pharma COO Douglas Kling sells $1.65 million in shares By Investing.com - Investing.com Canada

Apr 18, 2025

Apr 17, 2025

NewAmsterdam Pharma adds Adele Gulfo to its Board By Investing.com - Investing.com South Africa

Apr 17, 2025

Apr 17, 2025

Newamsterdam pharma COO Douglas Kling sells $1.65 million in shares - Investing.com Australia

Apr 17, 2025

Apr 17, 2025

NewAmsterdam Pharma adds Adele Gulfo to its Board - Investing.com

Apr 17, 2025

Apr 17, 2025

NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors - GlobeNewswire

Apr 17, 2025

Apr 17, 2025

NewAmsterdam Pharma Company N.V. Appoints Adele Gulfo to its Board of Directors - marketscreener.com

Apr 17, 2025

Apr 13, 2025

Arrowstreet Capital Limited Partnership Acquires New Shares in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 13, 2025

Apr 12, 2025

Sei Investments Co. Sells 14,456 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 12, 2025

Apr 11, 2025

NewAmsterdam Pharma (NAMS): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential - Insider Monkey

Apr 11, 2025

Apr 09, 2025

KLP Kapitalforvaltning AS Purchases Shares of 6,000 NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 09, 2025

Apr 08, 2025

The Analyst Verdict: NewAmsterdam Pharma Co In The Eyes Of 6 Experts - Benzinga

Apr 08, 2025

Apr 08, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Sets New 52-Week Low – Here’s Why - Defense World

Apr 08, 2025

Apr 08, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Receives $43.33 Average Price Target from Analysts - Defense World

Apr 08, 2025

Apr 07, 2025

Where are the Opportunities in (NAMSW) - news.stocktradersdaily.com

Apr 07, 2025

Apr 04, 2025

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Apr 04, 2025

Apr 04, 2025

NewAmsterdam Pharma Expands Team: 133,000 Shares Granted to Strategic New Hires - Stock Titan

Apr 04, 2025

Apr 04, 2025

NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September - MarketScreener

Apr 04, 2025

Apr 03, 2025

American Century Companies Inc. Acquires Shares of 346,572 NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 03, 2025

Apr 02, 2025

Teacher Retirement System of Texas Makes New $276,000 Investment in NewAmsterdam Pharma (NASDAQ:NAMS) - Defense World

Apr 02, 2025

Apr 01, 2025

When (NAMS) Moves Investors should Listen - news.stocktradersdaily.com

Apr 01, 2025

Mar 31, 2025

NewAmsterdam Pharma to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Mar 31, 2025

Mar 31, 2025

Leading Cardiovascular Drug Developer NewAmsterdam Sets Key Investor Presentation - Stock Titan

Mar 31, 2025

Mar 29, 2025

Newamsterdam Pharma CEO Michael Davidson sells shares for $281,000 By Investing.com - Investing.com Australia

Mar 29, 2025

Mar 29, 2025

Newamsterdam Pharma director James Topper buys $25,520 in shares - Investing.com Australia

Mar 29, 2025

Mar 29, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Shares Acquired by Swiss National Bank - Defense World

Mar 29, 2025

Mar 28, 2025

Newamsterdam pharma COO sells shares worth $376,000 By Investing.com - Investing.com Canada

Mar 28, 2025

Mar 28, 2025

Newamsterdam Pharma director James Topper buys $25,520 in shares By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

Newamsterdam Pharma CEO Michael Davidson sells shares for $281,000 - Investing.com India

Mar 28, 2025

Mar 28, 2025

Newamsterdam pharma COO sells shares worth $376,000 - Investing.com India

Mar 28, 2025

Mar 19, 2025

Newamsterdam Pharma COO Kling sells $2.36 million in stock By Investing.com - Investing.com Australia

Mar 19, 2025

Mar 19, 2025

Newamsterdam Pharma COO Kling sells $2.36 million in stock - Investing.com

Mar 19, 2025

Mar 18, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Shares Sold by US Bancorp DE - Defense World

Mar 18, 2025

Mar 14, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Receives $43.33 Consensus Price Target from Analysts - Defense World

Mar 14, 2025

Mar 12, 2025

Financial Metrics Exploration: Understanding NewAmsterdam Pharma Company NV (NAMS) Through Ratios - The Dwinnex

Mar 12, 2025

Mar 12, 2025

9,983 Shares in NewAmsterdam Pharma (NASDAQ:NAMS) Purchased by Keybank National Association OH - Defense World

Mar 12, 2025

Mar 11, 2025

(NAMS) Trading Advice - news.stocktradersdaily.com

Mar 11, 2025

Mar 10, 2025

A better buy-in window may exist right now for NewAmsterdam Pharma Company NV (NAMS) - SETE News

Mar 10, 2025

Mar 07, 2025

Newamsterdam pharma director James Topper buys $84,203 in shares By Investing.com - Investing.com Australia

Mar 07, 2025

Mar 06, 2025

Newamsterdam pharma director James Topper buys $84,203 in shares - Investing.com

Mar 06, 2025